JP2020535163A5 - - Google Patents

Download PDF

Info

Publication number
JP2020535163A5
JP2020535163A5 JP2020517424A JP2020517424A JP2020535163A5 JP 2020535163 A5 JP2020535163 A5 JP 2020535163A5 JP 2020517424 A JP2020517424 A JP 2020517424A JP 2020517424 A JP2020517424 A JP 2020517424A JP 2020535163 A5 JP2020535163 A5 JP 2020535163A5
Authority
JP
Japan
Prior art keywords
platelet lysate
fraction
platelet
lysate fraction
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020517424A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020535163A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/076244 external-priority patent/WO2019063683A1/en
Publication of JP2020535163A publication Critical patent/JP2020535163A/ja
Publication of JP2020535163A5 publication Critical patent/JP2020535163A5/ja
Pending legal-status Critical Current

Links

JP2020517424A 2017-09-27 2018-09-27 血小板溶解物画分を調製するための方法、血小板溶解物画分、及び中枢神経系の障害を処置するためのその使用 Pending JP2020535163A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17306284.5 2017-09-27
EP17306284 2017-09-27
PCT/EP2018/076244 WO2019063683A1 (en) 2017-09-27 2018-09-27 PROCESS FOR THE PREPARATION OF PLATELET LYSATE FRACTION, PLATELET LYSATE FRACTION AND USE THEREOF FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

Publications (2)

Publication Number Publication Date
JP2020535163A JP2020535163A (ja) 2020-12-03
JP2020535163A5 true JP2020535163A5 (https=) 2021-10-14

Family

ID=60083230

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020517424A Pending JP2020535163A (ja) 2017-09-27 2018-09-27 血小板溶解物画分を調製するための方法、血小板溶解物画分、及び中枢神経系の障害を処置するためのその使用

Country Status (11)

Country Link
US (1) US20230135837A1 (https=)
EP (1) EP3687554A1 (https=)
JP (1) JP2020535163A (https=)
CN (1) CN111107857A (https=)
AU (1) AU2018343875A1 (https=)
BR (1) BR112020006316A2 (https=)
CA (1) CA3076858A1 (https=)
IL (1) IL273482A (https=)
RU (1) RU2020112898A (https=)
TW (1) TW201914595A (https=)
WO (1) WO2019063683A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2840568C (en) * 2011-06-27 2021-05-04 Emory University Compositions, uses, and preparation of platelet lysates
TWI744300B (zh) * 2016-03-23 2021-11-01 里爾中央醫學中心 改良性熱處理的血小板顆粒裂解液在製備用於治療神經系統疾病的組合物的用途
US12570962B2 (en) * 2020-02-03 2026-03-10 Oklahoma Blood Institute Preparation of human platelet lysate (HPL) from refrigerated whole blood platelets
EP3881858A1 (en) * 2020-03-20 2021-09-22 Rok Pangersic Heat-treated platelet-derived growth factor extract for use in a method of preventing or treating a tissue defect

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4815063B2 (ja) * 2001-04-13 2011-11-16 きみ子 室伏 環状ホスファチジン酸を含むグリア細胞の増殖、分化及び/又は生存の促進のための薬剤
SE0501462L (sv) * 2005-06-23 2006-09-26 Proliff Ab Förfarande för framställning av blodplättslysat
JP5383498B2 (ja) * 2006-12-14 2014-01-08 ニューロノバ エービー メラノコルチン4レセプターの活性を低下させる薬剤を使用した、神経系の疾患または損傷の処置
ES2402144T3 (es) * 2010-05-25 2013-04-29 Gwowei Technology Co., Ltd. Lisado plaquetario inactivado que contiene factores de crecimiento empobrecido en PDGF y VEGF y su procedimiento de preparación
EP3107590B1 (en) * 2014-02-20 2021-11-17 Ortho Regenerative Technologies Inc. Freeze-dried polymer compositions for mixing with platelet rich plasma to form implants for tissue repair and/or compositions for therapeutic intra-articular injections
EP3143130B1 (en) * 2014-05-16 2024-03-06 Mayo Foundation for Medical Education and Research Cell culture media compositions for primary cells

Similar Documents

Publication Publication Date Title
JP2020535163A5 (https=)
Khanna et al. Therapeutic strategies for the treatment of tauopathies: Hopes and challenges
JP2020523398A5 (https=)
Freskgård et al. Antibody therapies in CNS diseases
JP2016509011A5 (https=)
RU2020112898A (ru) Способ получения фракции лизата тромбоцитов, фракция лизата тромбоцитов и ее применение для лечения расстройств центральной нервной системы
NZ722927A (en) Aerosol pirfenidone and pyridone analog compounds and uses thereof
EP4707400A3 (en) Gene therapies for lysosomal disorders
WO2003051374A3 (en) SEQUESTRATION OF Aβ IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES
HRP20210522T1 (hr) Antitijela specifična za hiperfosforilirani tau i načini njihove uporabe
WO2009149486A3 (en) Compounds for treating beta-amyloidoses
MX2020013115A (es) Compuestos de tetrahidrobenzofuro[2,3-c]piridina y beta-carbolina para el tratamiento, el alivio o la prevencion de trastornos asociados con los agregados de tau.
WO2020097511A3 (en) Messenger rna therapy for treatment of ocular diseases
JP2017532343A5 (https=)
ZA202201828B (en) Therapeutic fusion proteins
RU2017128296A (ru) Композиция для лечения бесплодия
WO2009105641A3 (en) Preventing and treating amyloid-beta deposition by stimulation of innate immunity
JP2017538753A5 (https=)
WO2018013775A3 (en) Granulin compositions and uses related thereto
IL308645A (en) Viral vectors comprising rdh12 coding regions and methods of treating retinal dystrophies
JP2018517767A5 (https=)
WO2009155069A8 (en) Compositions and methods for treating psychiatric and neurodegenerative disorders
WO2018020285A3 (en) Flow capture device and method for removing cells from blood
JP2017508768A5 (https=)
RU2020101295A (ru) Способ получения объединенного лизата тромбоцитов человека, объединенный лизат тромбоцитов человека и его применение для лечения неврологических нарушений